Daniel Mark James 4
4 · ATOSSA THERAPEUTICS, INC. · Filed Oct 21, 2025
Insider Transaction Report
Form 4
Daniel Mark James
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-10-14+578,000→ 578,000 totalExercise: $1.03Exp: 2035-10-14→ Common Stock (578,000 underlying)
Footnotes (1)
- [F1]The options shall vest with respect to 25% on October 14, 2026, with the remaining 75% to vest in equal quarterly installments over the follwing three years, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.